Burrows Francis 4
4 · Kura Oncology, Inc. · Filed Jan 28, 2025
Insider Transaction Report
Form 4
Burrows Francis
Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-01-28$7.87/sh−1,320$10,391→ 20,705 total - Sale
Common Stock
2025-01-28$7.87/sh−846$6,660→ 22,025 total
Footnotes (2)
- [F1]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/21.
- [F2]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.